<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Gastric Ulcer | Family Medicine Reference</title>
  <style>
    body {
      font-family: "Segoe UI", Tahoma, Geneva, Verdana, sans-serif;
      background-color: #f8f9fa;
      color: #212529;
      line-height: 1.6;
      margin: 40px;
    }
    h1, h2, h3 {
      color: #004085;
    }
    section {
      background: #ffffff;
      border-radius: 8px;
      box-shadow: 0 2px 5px rgba(0,0,0,0.1);
      padding: 25px;
      margin-bottom: 20px;
    }
    table {
      width: 100%;
      border-collapse: collapse;
      margin: 10px 0;
    }
    th, td {
      border: 1px solid #dee2e6;
      padding: 10px;
      text-align: left;
    }
    th {
      background-color: #e9ecef;
    }
    .source {
      font-size: 0.9em;
      color: #555;
    }
    a {
      color: #0069d9;
      text-decoration: none;
    }
    a:hover {
      text-decoration: underline;
    }
  </style>
</head>
<body>

  <h1>Gastric Ulcer</h1>

  <section>
    <h2>Definition</h2>
    <p>
      A <strong>gastric ulcer</strong> is a type of <strong>peptic ulcer</strong> that occurs in the gastric mucosa, 
      typically along the lesser curvature between the corpus and antrum.  
      It represents a mucosal defect ≥ 0.5 cm in diameter penetrating through the muscularis mucosae.
    </p>
  </section>

  <section>
    <h2>Etiology</h2>
    <ul>
      <li><strong>Helicobacter pylori infection</strong> (most common cause worldwide)</li>
      <li><strong>NSAID use</strong> (impairs prostaglandin synthesis and mucosal protection)</li>
      <li>Excess gastric acid secretion (less common than in duodenal ulcers)</li>
      <li>Stress-related mucosal damage (e.g., severe illness, burns)</li>
      <li>Smoking, alcohol, and corticosteroid use (contributory factors)</li>
    </ul>
  </section>

  <section>
    <h2>Clinical Features</h2>
    <ul>
      <li><strong>Epigastric pain</strong> – classically worsens <em>shortly after meals</em>.</li>
      <li>Pain described as burning or gnawing; may radiate to the back.</li>
      <li>Associated symptoms: belching, bloating, nausea, or early satiety.</li>
      <li>Patients may experience <strong>weight loss</strong> due to food avoidance.</li>
    </ul>
    <p><em>In contrast, duodenal ulcer pain often improves with food and leads to weight gain.</em></p>
  </section>

  <section>
    <h2>Complications</h2>
    <ul>
      <li><strong>Bleeding</strong> – from erosion into the left gastric artery (hematemesis or melena).</li>
      <li><strong>Perforation</strong> – presenting with sudden severe abdominal pain, rigidity, and pneumoperitoneum.</li>
      <li><strong>Penetration</strong> – ulcer extends into adjacent organs (e.g., pancreas).</li>
      <li><strong>Gastric outlet obstruction</strong> – due to edema or fibrosis from chronic ulcers.</li>
      <li><strong>Malignant transformation</strong> – up to 5–10% risk; biopsy always indicated.</li>
    </ul>
  </section>

  <section>
    <h2>Diagnosis</h2>
    <h3>Initial Evaluation</h3>
    <ul>
      <li>Assess for risk factors: NSAID use, H. pylori, smoking, alcohol.</li>
      <li>Basic labs: CBC (for anemia), metabolic panel, and fecal occult blood test if bleeding suspected.</li>
    </ul>

    <h3>Noninvasive Tests</h3>
    <ul>
      <li><strong>H. pylori testing:</strong> urea breath test or stool antigen test.</li>
    </ul>

    <h3>Esophagogastroduodenoscopy (EGD)</h3>
    <ul>
      <li><strong>Gold standard</strong> for diagnosis.</li>
      <li>Allows direct visualization and biopsy to rule out malignancy.</li>
      <li><strong>Benign ulcers:</strong> smooth base, regular margins.</li>
      <li><strong>Malignant ulcers:</strong> irregular, heaped-up margins with nodularity.</li>
    </ul>

    <h3>Biopsy Indications</h3>
    <ul>
      <li>All gastric ulcers (to exclude carcinoma).</li>
      <li>Multiple biopsies from ulcer edges and base, and additional samples for H. pylori detection.</li>
    </ul>
  </section>

  <section>
    <h2>Treatment</h2>
    <h3>General Measures</h3>
    <ul>
      <li>Discontinue NSAIDs and avoid alcohol and tobacco.</li>
      <li>Encourage small, frequent meals and avoid eating before bedtime.</li>
    </ul>

    <h3>Pharmacologic Therapy</h3>
    <table>
      <tr><th>Indication</th><th>Treatment</th></tr>
      <tr><td>H. pylori positive</td><td>Eradication therapy: PPI + 2 antibiotics (e.g., amoxicillin + clarithromycin) for 14 days.</td></tr>
      <tr><td>H. pylori negative</td><td>PPI monotherapy for 8 weeks.</td></tr>
      <tr><td>NSAID-induced</td><td>Stop NSAID; PPI for 8–12 weeks or use misoprostol if NSAID must be continued.</td></tr>
    </table>

    <h3>Supportive Medications</h3>
    <ul>
      <li><strong>PPIs:</strong> Omeprazole 20–40 mg daily for ≥8 weeks.</li>
      <li><strong>H<sub>2</sub> blockers:</strong> Famotidine 20 mg twice daily (alternative if PPI not tolerated).</li>
      <li><strong>Sucralfate:</strong> 1 g four times daily – forms a protective mucosal barrier.</li>
    </ul>
  </section>

  <section>
    <h2>Follow-Up</h2>
    <ul>
      <li>Repeat EGD with biopsy to confirm healing and rule out malignancy.</li>
      <li>Ensure eradication of H. pylori if previously positive.</li>
      <li>Monitor for recurrence if symptoms persist or risk factors remain.</li>
    </ul>
  </section>

  <section>
    <h2>Prevention</h2>
    <ul>
      <li>Avoid NSAIDs and smoking.</li>
      <li>Use PPIs or misoprostol for patients requiring chronic NSAID therapy.</li>
      <li>Limit alcohol and caffeine intake.</li>
    </ul>
  </section>

  <p class="source">
    Source: <a href="https://www.amboss.com/us/knowledge/peptic-ulcer-disease?utm_medium=chatgpt-plugin&utm_source=chatgpt" target="_blank">
    AMBOSS: Peptic Ulcer Disease</a>
  </p>

</body>
</html>
